Business analyst Shaun Rein clashes at North Meridian with former Trump ambassador to Denmark Carla Sands on what Trump is achieving on China, Trump’s trade strategy, Taiwan, Iran, and whether Washington still has the leverage over Beijing that it thinks it does. Rein is the author of The Split: Finding the Opportunities in China’s Economy in the New World Order.Read More →

Drug deals dominated much of the international relations between biotech companies. But now, another change: the way China’s biotech companies structure their innovation shows a major shift, known widely as “NewCo,” says long-term China lawyer Mark Schaub on the website of his law firm, King&Wood.Read More →

In the past, China purchased licenses to sell medicines from Western companies. But today, China sells its own medicines to the West. The previously attractive market has changed profoundly, says China lawyer Mark Schaub on the website of his law firm King&Wood. “For many international companies if the question is “How do we sell into China?” then they may be increasingly playing yesterday’s game,” he writesRead More →

Business analyst Shaun Rein, author of The Split: Finding the Opportunities in China’s Economy in the New World Order, discusses the push for a war with China, now that NATO Secretary-General Mark Rutte has identified China as the real enemy for the organisation, even though China is eager to improve relations with European countries, he tells George Galloway at Moats. Read More →